Adaptin Bio, INC

8-K

Market Movers (8-K)

OQB
APTN
Adaptin Bio, INC
8-K: Adaptin Bio Opens Glioblastoma Trial for APTN-101
Adaptin Bio, Inc. has announced the opening of enrollment for a Phase 1 clinical trial of its BRiTE therapeutic, APTN-101, targeting glioblastoma.
Capital raise